Prognostic Factors for Patients With Advanced Colorectal Cancer and Symptomatic Brain Metastases

Published:September 18, 2014DOI:



      Increased rates of long-term survival after CRC diagnosis are accompanied by increases in the incidence of BMs. Here, we retrospectively evaluated the outcomes of patients with BMs from CRC.

      Materials and Methods

      We reviewed the records of 1364 patients with CRC treated between January 1999 and December 2010 at Kinki University Hospital in Japan. Twenty-five of these patients developed BMs. Log-rank tests and Cox regression analyses were used to assess potential prognostic factors for survival.


      Among the patients with BMs, BMs developed a median of 25.3 (range, 11.4-111) months after primary CRC surgery. There was a median of 2 BMs per patient. Eleven patients had solitary BMs. Concomitant extracerebral metastases, particularly lung metastases, were found in 23 patients. Twenty-three patients were receiving systemic chemotherapy at the time of diagnosis with BMs. After the development of BMs, the median survival time (MST) was 2.8 months. The MST was 4.8 months among patients who underwent neurosurgical resection (n = 6) or stereotactic surgery (n = 9, including combined therapy in 2 patients) and 1.5 months among patients who underwent whole-brain radiotherapy only or best supportive care (n = 12). In multivariate analysis, single BMs and additional systemic chemotherapy after BMs diagnosis were significantly associated with overall survival (P = .022 and .023, respectively).


      Our results suggest that advancements in continuing systemic chemotherapy prolong survival among patients with BMs from CRC. Clinicians should be especially aware of BMs in patients with lung metastases.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Clinical Colorectal Cancer
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Tan W.S.
        • Ho K.S.
        • Eu K.W.
        Brain metastases in colorectal cancers.
        World J Surg. 2009; 33: 817-821
        • Kobayashi H.
        • Mochizuki H.
        • Sugihara K.
        • et al.
        Characteristics of recurrence and surveillance tools after curative resection for colorectal cancer: a multicenter study.
        Surgery. 2007; 141: 67-75
        • Jamal A.
        • Siegel R.
        • Ward E.
        • et al.
        Cancer statics, 2009.
        CA Cancer J Clin. 2009; 59: 225-249
        • Schouten L.J.
        • Rutten J.
        • Huveneers H.A.
        • et al.
        Incidence of brain metastases in a cohort of patients with carcinoma of the breast, colon, kidney, and lung and melanoma.
        Cancer. 2002; 94: 2698-2705
        • Ko F.C.
        • Liu J.M.
        • Chen W.S.
        • et al.
        Risk and patterns of brain metastases in colorectal cancer: 27-year experience.
        Dis Colon Rectum. 1999; 42: 1467-1471
        • Floyd C.E.
        • Stirling C.T.
        • Cohn Jr., I.
        Cancer of the colon, rectum and anus: review of 1,678 cases.
        Ann Surg. 1966; 163: 829-837
        • Sundermayer M.L.
        • Meropol N.J.
        • Rogatko A.
        • et al.
        Changing patterns of bone and brain metastases in patients with colorectal cancer.
        Clin Colorectal Cancer. 2005; 5: 108-113
        • Gavrilovic I.T.
        • Posner J.B.
        Brain metastases: epidemiology and pathophysiology.
        J Neurooncol. 2005; 75: 5-14
        • Go P.H.
        • Klaassen Z.
        • Meadows M.C.
        • Chamberlein R.S.
        Gastrointestinal cancer and brain metastasis: a rare and ominous sign.
        Cancer. 2011; 117: 3630-3640
        • Gaspar L.
        • Scott C.
        • Rotman M.
        • et al.
        Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials.
        Int J Radiat Oncol Biol Phys. 1997; 37: 745-751
        • Golden D.W.
        • Lamborn R.L.
        • McRermott W.
        • et al.
        Prognostic factors and grading systems for overall survival in patients treated with radiosurgery for brain metastases: Variation by primary site.
        J Neurosurg. 2008; 109: 77-86
        • Cairncross J.G.
        • Kim J.H.
        • Posner J.B.
        Radiation therapy for brain metastases.
        Ann Neurol. 1980; 7: 529-541
        • Fabi A.
        • Felici A.
        • Metro G.
        • et al.
        Brain metastases from solid tumors: disease outcome according to type of treatment and therapeutic resources of the treating center.
        J Exp Clin Cancer Res. 2011; 30: 10
        • Alden T.D.
        • Gianino J.W.
        • Saclarides T.J.
        Brain metastases from colorectal cancer.
        Dis Colon Rectum. 1996; 39: 541-545
        • Kruser T.J.
        • Chao S.T.
        • Elson P.
        • et al.
        Multidisciplinary management of colorectal brain metastases: a retrospective study.
        Cancer. 2008; 113: 158-165
        • Hammoud M.A.
        • McCutcheon I.E.
        • Elsouki R.
        • et al.
        Colorectal carcinoma and brain metastasis: distribution, treatment, and survival.
        Ann Surg Oncol. 1996; 3: 453-463
        • Noura S.
        • Ohue M.
        • Shingai T.
        • et al.
        Brain metastasis from colorectal cancer: prognostic factors and survival.
        J Surg Oncol. 2012; 106: 144-148
        • Tillibert S.
        • Delattre J.Y.
        Palliative care in patients with brain metastases.
        Curr Opin Oncol. 2005; 17: 588-592
        • Suzuki Y.
        • Yamaguchi T.
        • Matsumoto H.
        • et al.
        Prognostic factors and treatment effects in patients with curatively resected brain metastasis from colorectal cancer.
        Dis Colon Rectum. 2013; 57: 56-63
        • Fokas E.
        • Henzel M.
        • Hamm K.
        • et al.
        Multidisciplinary treatment of brain metastases derived from colorectal cancer incorporating stereotactic radiosurgery: analysis of 78 patients.
        Clin Colorectal Cancer. 2011; 10: 121-125
        • Niede C.
        • Pawinski A.
        • Balteskard L.
        Colorectal cancer metastatic to the brain: time trends in presentation and outcome.
        Oncology. 2009; 76: 369-374
        • Jung M.
        • Ahn J.B.
        • Chang J.H.
        • et al.
        Brain metastases from colorectal carcinoma: prognostic factors and outcome.
        J Neurooncol. 2011; 101: 49-55
        • Patchell R.A.
        • Tibbs P.A.
        • Walsh J.W.
        • et al.
        A randomized trial of surgery in the treatment of single metastases to the brain.
        N Engl J Med. 1990; 322: 494-500
        • Sobin L.H.
        • Wittekind C.
        TNM Classification of Malignant Tumours.
        7th ed. Weiley-Liss, New York2009
        • Amichetti M.A.
        • Lay Giancarlo
        • Dessi M.
        • et al.
        Results of whole brain radiation therapy in patients with brain metastases from colorectal carcinoma.
        Tumori. 2005; 91: 163-165
        • Mege D.
        • Ouaissi M.
        • Fuks D.
        • et al.
        Patients with brain metastases from colorectal cancer are not condemned.
        Anticancer Res. 2013; 33: 5645-5648
        • Aprile G.
        • Zanon E.
        • Tuniz F.
        • et al.
        Neurosurgical management and postoperative whole-brain radiotherapy for colorectal cancer patients with symptomatic brain metastases.
        J Cancer Res Clin Oncol. 2009; 135: 451-457
        • Noordijk E.M.
        • Vecht C.J.
        • Haaxma-Reiche H.
        • et al.
        The choice of treatment of single brain metastases should be based on extracranial tumor activity and age.
        Int J Radiat Oncol Biol Phys. 1994; 29: 711-717
        • Farnell G.F.
        • Buckner J.C.
        • Cascino T.L.
        • et al.
        Brain metastases from colorectal carcinoma. The long term survivors.
        Cancer. 1996; 78: 711-716
        • Winston K.R.
        • Walsh J.W.
        • Fischer E.G.
        Results of operative treatment of intracranial metastatic tumors.
        Cancer. 1980; 45: 2639-2645